Rocket Pharmaceuticals, Inc. (RCKT)
2.255
-0.14
(-5.65%)
USD |
NASDAQ |
Nov 13, 10:06
Rocket Pharmaceuticals Free Cash Flow (Quarterly) : -39.62M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -39.62M |
| March 31, 2026 | -45.49M |
| December 31, 2025 | -34.92M |
| September 30, 2025 | -50.37M |
| June 30, 2025 | -49.03M |
| March 31, 2025 | -56.17M |
| December 31, 2024 | -47.27M |
| September 30, 2024 | -53.72M |
| June 30, 2024 | -55.78M |
| March 31, 2024 | -58.92M |
| December 31, 2023 | -34.02M |
| September 30, 2023 | -61.84M |
| June 30, 2023 | -55.05M |
| March 31, 2023 | -60.62M |
| December 31, 2022 | -59.32M |
| September 30, 2022 | -44.41M |
| June 30, 2022 | -41.98M |
| March 31, 2022 | -41.22M |
| December 31, 2021 | -31.54M |
| September 30, 2021 | -31.71M |
| June 30, 2021 | -41.28M |
| March 31, 2021 | -24.55M |
| December 31, 2020 | -32.02M |
| September 30, 2020 | -21.75M |
| June 30, 2020 | -27.27M |
| Date | Value |
|---|---|
| March 31, 2020 | -28.22M |
| December 31, 2019 | -28.99M |
| September 30, 2019 | -17.56M |
| June 30, 2019 | -24.65M |
| March 31, 2019 | -16.74M |
| December 31, 2018 | -21.70M |
| September 30, 2018 | -12.09M |
| June 30, 2018 | -9.847M |
| March 31, 2018 | -11.61M |
| December 31, 2017 | -6.019M |
| September 30, 2017 | -4.095M |
| June 30, 2017 | -2.754M |
| March 31, 2017 | -3.854M |
| December 31, 2016 | -11.28M |
| September 30, 2016 | -9.24M |
| June 30, 2016 | -8.224M |
| March 31, 2016 | -9.008M |
| December 31, 2015 | -7.133M |
| September 30, 2015 | -4.615M |
| June 30, 2015 | -4.087M |
| March 31, 2015 | -1.993M |
| December 31, 2014 | -2.994M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -1.855M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 53.83M |
| Intellia Therapeutics, Inc. | -86.32M |
| Beam Therapeutics, Inc. | -111.96M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |